The FDA Spies On Its Own Scientists — Cloaks and Daggers Emerge When Scientists and Authorities Clash
A lurid story of intramural hijinks at the FDA shows how far from mission an organization can drift when it gets its priorities wrong.
A lurid story of intramural hijinks at the FDA shows how far from mission an organization can drift when it gets its priorities wrong.
The RCUK announces its OA plans, including a six-month embargo. Now, speculation snaps into reality, and we will see if a number of lurking unintended consequences come to pass.
Science policy is often guided by poorly-constructed and highly biased survey results. Shouldn’t we demand more?
Stray thoughts from vacationland. You may see these again.
An interesting video showing one reason why it makes sense for food in an ad to look different from food you’re served.
Fifty-one journals are suspended from the Journal Citation Report for “anomalous citation patterns.” Whether or not you agree with the impact factor, sanctions help maintain the integrity of the scientific publishing enterprise for everyone.
A fascinating set of new video techniques being developed at MIT hint at how cameras might someday intervene in crib death, help diagnose heart disease, and more.
Consent and confidentiality concerns around “Big Data” in medicine should give enthusiasts for a data-rich scientific world pause. Things are more complex, and the answers so far are inadequate.
Two separate but coincidental stances toward money and OA show that when it comes to getting things done, there’s nothing quite as useful as the right incentive — even when it turns OA principles on their head.
A British explication of some nifty bar bets you can try on your friends.
Oops. Sorry.
Two funny videos of processes in scientific life which many of us can use a good laugh about. Warning — Hitler, unsurprisingly, swears like a sailor when he’s frustrated. The peer review send-up: And, if you want more, there’s the […]
3:30 p.m.: David C. notes that publishers are in an interesting quandary — they’re castigated for making a profit, yet they’re asked to make huge ongoing investments to make information more findable and usable. Publishers need to bring out the […]
The Big Deal has emerged because it had to. Where do we go from here? The answer isn’t clear.
Science begins from a simple premise, then gets really complicated. It’s good to return to the basics, courtesy of this brief primer from the legendary Richard Feynman.